The EVs derived from iPSC-derived cardiomyocytes (iCMs) have shown the ability to promote angiogenesis and enhance the expression of dystrophin for Duchenne muscular dystrophy [55]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.